Manipal Health Enterprises Ltd
Incorporated in 2010, Manipal Health
Enterprises Limited is a healthcare
service providers, operating a large
network of multi-specialty hospitals,
clinics, and diagnostic centres across
the country.[1]
- Market Cap ₹ 85,960 Cr.
- Current Price ₹ 654
- High / Low ₹ 815 / 597
- Stock P/E 97.1
- Book Value ₹
- Dividend Yield 0.00 %
- ROCE 12.1 %
- ROE 12.7 %
- Face Value ₹ 2.00
Pros
- Company has delivered good profit growth of 76.8% CAGR over last 5 years
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Hospital
Part of BSE IPO BSE Healthcare Nifty IPO
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| 1,813 | 3,975 | 4,806 | 6,172 | 8,242 | 10,336 | |
| 1,483 | 3,054 | 3,527 | 4,489 | 6,115 | 7,725 | |
| Operating Profit | 330 | 921 | 1,279 | 1,683 | 2,127 | 2,611 |
| OPM % | 18% | 23% | 27% | 27% | 26% | 25% |
| -47 | 293 | -48 | -86 | 134 | 111 | |
| Interest | 205 | 326 | 329 | 455 | 512 | 864 |
| Depreciation | 183 | 256 | 315 | 397 | 507 | 680 |
| Profit before tax | -105 | 632 | 586 | 745 | 1,242 | 1,178 |
| Tax % | 30% | 14% | 27% | 28% | 13% | 22% |
| -138 | 542 | 429 | 533 | 1,082 | 917 | |
| EPS in Rs | -1.34 | 4.77 | 3.78 | 5.24 | 9.22 | 7.56 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 42% |
| 3 Years: | 29% |
| TTM: | 25% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 77% |
| 3 Years: | 22% |
| TTM: | -10% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 16% |
| 3 Years: | 17% |
| Last Year: | 13% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Equity Capital | 69 | 76 | 76 | 76 | 77 | 236 |
| Reserves | 1,064 | 2,732 | 3,166 | 3,940 | 5,770 | 8,190 |
| 1,575 | 2,017 | 2,184 | 5,130 | 6,385 | 12,863 | |
| 1,316 | 2,521 | 2,337 | 1,612 | 1,658 | 3,446 | |
| Total Liabilities | 4,024 | 7,346 | 7,763 | 10,757 | 13,890 | 24,735 |
| 2,278 | 4,582 | 4,784 | 8,158 | 9,826 | 18,753 | |
| CWIP | 412 | 1,089 | 1,033 | 42 | 614 | 795 |
| Investments | 551 | 768 | 1,038 | 1,121 | 1,776 | 2,675 |
| 784 | 907 | 908 | 1,436 | 1,675 | 2,511 | |
| Total Assets | 4,024 | 7,346 | 7,763 | 10,757 | 13,890 | 24,735 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| 426 | 805 | 1,149 | 1,389 | 1,570 | 2,078 | |
| -188 | -1,711 | -994 | -846 | -2,544 | -7,025 | |
| -280 | 941 | -144 | -250 | 904 | 4,954 | |
| Net Cash Flow | -42 | 34 | 12 | 293 | -70 | 8 |
| Free Cash Flow | 334 | 629 | 823 | 1,062 | 520 | 767 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 106% | 98% | 105% | 100% | 87% | 96% |
Ratios
Consolidated / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Debtor Days | 26 | 27 | 24 | 27 | 28 | 33 |
| Inventory Days | 20 | 28 | 23 | 30 | 29 | 29 |
| Days Payable | 371 | 246 | 283 | 330 | 245 | 253 |
| Cash Conversion Cycle | -325 | -190 | -236 | -273 | -188 | -190 |
| Working Capital Days | -95 | -113 | -56 | -58 | -40 | -70 |
| ROCE % | 18% | 19% | 18% | 16% | 12% |
Documents
Announcements
-
Board Meeting Intimation for Prior Intimation Of Board Meeting
- Board meets November 13, 2026 to approve Q2 and half-year FY2027 unaudited results.
- Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011.
-
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
- Promoter group MEMG International created pledge over Manipal Health shares on 30 October 2026.
-
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
- GST orders confirmed ₹3.78 crore and ₹4.23 crore demands, with penalties and interest, at subsidiary.
-
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
- Promoter encumbrance disclosure filed on 29 Oct 2026; no encumbrance change shown.
Concalls
-
Aug 2026Transcript PPT REC
-
Aug 2026PPT
Business Profile:[1][2]
Manipal Health Enterprises is one of India's largest private multispecialty hospital chains, providing healthcare services across the entire continuum of care, from outpatient consultations and diagnostics to tertiary and quaternary care, organ transplantation, robotic surgery and complex interventions.